RBP5
Retinol-binding protein 5
Also known as: CRBPIII, RET5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P82980
- Gene
- RBP5
- Ensembl
- ENSG00000139194
- Chromosome
- 12
- Canonical length
- 135 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus,Vesicles
OverviewNCBI Gene
The protein encoded by this gene is a cellular retinol-binding protein expressed highly in kidney and liver. Down-regulation of the encoded protein in hepatocellular carcinoma was associated with large tumor size and poor patient survival rates. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
135 residues, UniProt reviewed canonical sequence.
>P82980|RBP5
1 MPPNLTGYYR FVSQKNMEDY LQALNISLAV RKIALLLKPD KEIEHQGNHM TVRTLSTFRN
61 YTVQFDVGVE FEEDLRSVDG RKCQTIVTWE EEHLVCVQKG EVPNRGWRHW LEGEMLYLEL
121 TARDAVCEQV FRKVRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RBP5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 453 nTPM
Expression across tissuesHPA
Tissue
- kidney: 453 nTPM
- liver: 329 nTPM
- spleen: 97 nTPM
- lymph node: 29 nTPM
- small intestine: 20 nTPM
- tonsil: 20 nTPM
Single-cell type
- hepatocytes: 217 nCPM
- epididymal efferent duct absorptive cells: 42 nCPM
- proximal tubule cells: 41 nCPM
- vascular endothelial cells: 7.3 nCPM
- loop of henle epithelial cells: 6.6 nCPM
- hepatic stellate cells: 6.5 nCPM
Immune cell
- T-reg: 0.3 nTPM
- basophil: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- medulla oblongata: 2.3 nTPM
- cerebral cortex: 1.9 nTPM
- midbrain: 1.9 nTPM
- cerebellum: 1.8 nTPM
- pons: 1.8 nTPM
- thalamus: 1.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.59
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.4
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RBP5 as an antibody target. Whether an autoantibody or antibody against RBP5 could matter depends on whether native RBP5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RBP5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RBP5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...